# Notal Vision Ltd. clinical trials: 25 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials with Notal Vision Ltd. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Notal Vision Ltd.: 25 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/notal-vision-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 27, 2020 | NCT04241198 | Home Retinal Imaging Using NOTAL-OCT V3.0 | Notal Vision Ltd. | Observational | Completed | A. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing... | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04241198) |
| September 6, 2019 | NCT04078672 | Retinal Imaging Using NOTAL-OCT V3.0 | Notal Vision Ltd. | Not applicable | Completed | AMD, DR | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04078672) |
| May 31, 2019 | NCT03969303 | NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients | Notal Vision Ltd. | Observational | Completed | AMD - Age-Related Macular Degeneration, Diabetic Macular Edema | 287 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03969303) |
| July 26, 2018 | NCT03600519 | Retinal Imaging Using NOTAL-OCT V2.5 | Notal Vision Ltd. | Observational | Completed | AMD | 87 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03600519) |
| December 14, 2017 | NCT03374020 | Retinal Imaging Using NOTAL-OCT | Notal Vision Ltd. | Observational | Completed | Age-Related Macular Degeneration, Diabetic Retinopathy | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03374020) |
| September 1, 2017 | NCT03270865 | Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging | Notal Vision Ltd. | Not applicable | Completed | AMD Population - Intermediate or Advanced AMD, DR Population- With or Without Diabetic Macular Edema | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03270865) |
| January 25, 2017 | NCT03030729 | Macular Thickness Measurements Using Retinal-thickness OCT | Notal Vision Ltd. | Observational | Completed | Age-Related Macular Degeneration, Diabetic Retinopathy | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03030729) |
| April 18, 2011 | NCT01336907 | Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal... | Notal Vision Ltd. | Observational | Withdrawn | Age Related Macular Degeneration, Choroidal Neovascularization | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01336907) |
| April 13, 2011 | NCT01334294 | Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration, Choroidal Neovascularization | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01334294) |
| April 14, 2010 | NCT01103505 | HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device | Notal Vision Ltd. | Not applicable | Completed | Age Related Macular Degeneration | 1,520 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01103505) |
| March 9, 2010 | NCT01083147 | Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment | Notal Vision Ltd. | Observational | Completed | Age-Related Macular Degeneration | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01083147) |
| February 23, 2010 | NCT01073592 | Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization... | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01073592) |
| November 10, 2009 | NCT01010997 | Foresee Home for Monitoring Age Related Macular Degeneration (AMD) | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01010997) |
| August 21, 2009 | NCT00963339 | Age-Related Macular Degeneration (AMD) - Usability Study | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00963339) |
| April 21, 2009 | NCT00884637 | Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00884637) |
| October 21, 2008 | NCT00776451 | Usability of the PreView PHP for Home Use in Intermediate AMD Patients | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00776451) |
| September 8, 2008 | NCT00748384 | Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00748384) |
| June 6, 2008 | NCT00692887 | Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in... | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00692887) |
| January 29, 2008 | NCT00604071 | Sensitivity of the Home Macular Perimeter (HMP) | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration, Choroidal Neovascularization | 99 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00604071) |
| January 29, 2008 | NCT00603850 | Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00603850) |
| January 17, 2008 | NCT00596388 | Usage of the Home Macular Perimeter (HMP) | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00596388) |
| January 16, 2008 | NCT00595998 | Sensitivity and Specificity of the Home Macular Perimeter (HMP) | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00595998) |
| January 14, 2008 | NCT00592826 | HMP (Home Macular Perimeter) -Usability Trial | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00592826) |
| August 1, 2006 | NCT00359008 | PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV) | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 336 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00359008) |
| July 31, 2006 | NCT00358345 | PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization | Notal Vision Ltd. | Observational | Completed | Age Related Macular Degeneration | 347 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00358345) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 3 |
| Observational | 22 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 24 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Macular Degeneration | 21 |
| Choroidal Neovascularization | 7 |
| Diabetic Retinopathy | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Employment agencies in the United States](https://specstream.ai/data/businesses/employment-agencies/united-states)
- [Jamaican restaurants in the United States](https://specstream.ai/data/businesses/jamaican-restaurants/united-states)
- [Powder coating companies in the United States](https://specstream.ai/data/businesses/powder-coating-companies/united-states)
- [TV service providers in the United States](https://specstream.ai/data/businesses/tv-service-providers/united-states)
- [Biotechnology companies in the United States](https://specstream.ai/data/businesses/biotechnology-companies/united-states)
- [Energy management companies in the United States](https://specstream.ai/data/businesses/energy-management-companies/united-states)
